Liver Journals

High Impact List of Articles

• Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik

  Research Paper: Clinical Investigation

• Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik

  Research Paper: Clinical Investigation

• Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik

  Research Paper: Clinical Investigation

• Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik

  Research Paper: Clinical Investigation

• Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik

  Research Paper: Clinical Investigation

• Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik

  Research Paper: Clinical Investigation

• Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik

  Research Paper: Clinical Investigation

• Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik

  Research Paper: Clinical Investigation

• Utilization of informatics for integrating biology and the bedside to access preliminary outcome data of post-operative complication of spine surgery associated with diabetes mellitus Tomoko Tanaka, Abu Saleh Mohammad Mosa, N Scott Litofsky

  Research Article: Clinical Investigation

• Utilization of informatics for integrating biology and the bedside to access preliminary outcome data of post-operative complication of spine surgery associated with diabetes mellitus Tomoko Tanaka, Abu Saleh Mohammad Mosa, N Scott Litofsky

  Research Article: Clinical Investigation

• Utilization of informatics for integrating biology and the bedside to access preliminary outcome data of post-operative complication of spine surgery associated with diabetes mellitus Tomoko Tanaka, Abu Saleh Mohammad Mosa, N Scott Litofsky

  Research Article: Clinical Investigation

• Utilization of informatics for integrating biology and the bedside to access preliminary outcome data of post-operative complication of spine surgery associated with diabetes mellitus Tomoko Tanaka, Abu Saleh Mohammad Mosa, N Scott Litofsky

  Research Article: Clinical Investigation

• Utilization of informatics for integrating biology and the bedside to access preliminary outcome data of post-operative complication of spine surgery associated with diabetes mellitus Tomoko Tanaka, Abu Saleh Mohammad Mosa, N Scott Litofsky

  Research Article: Clinical Investigation

• Utilization of informatics for integrating biology and the bedside to access preliminary outcome data of post-operative complication of spine surgery associated with diabetes mellitus Tomoko Tanaka, Abu Saleh Mohammad Mosa, N Scott Litofsky

  Research Article: Clinical Investigation

• Utilization of informatics for integrating biology and the bedside to access preliminary outcome data of post-operative complication of spine surgery associated with diabetes mellitus Tomoko Tanaka, Abu Saleh Mohammad Mosa, N Scott Litofsky

  Research Article: Clinical Investigation

• Utilization of informatics for integrating biology and the bedside to access preliminary outcome data of post-operative complication of spine surgery associated with diabetes mellitus Tomoko Tanaka, Abu Saleh Mohammad Mosa, N Scott Litofsky

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Improving the implementation of evidence-based knowledge in healthcare Bernard Burnand

  Editorial: Clinical Investigation

• Improving the implementation of evidence-based knowledge in healthcare Bernard Burnand

  Editorial: Clinical Investigation

• Improving the implementation of evidence-based knowledge in healthcare Bernard Burnand

  Editorial: Clinical Investigation

• Improving the implementation of evidence-based knowledge in healthcare Bernard Burnand

  Editorial: Clinical Investigation

• Improving the implementation of evidence-based knowledge in healthcare Bernard Burnand

  Editorial: Clinical Investigation

• Improving the implementation of evidence-based knowledge in healthcare Bernard Burnand

  Editorial: Clinical Investigation

• Improving the implementation of evidence-based knowledge in healthcare Bernard Burnand

  Editorial: Clinical Investigation

• Improving the implementation of evidence-based knowledge in healthcare Bernard Burnand

  Editorial: Clinical Investigation

• Quality data collection: paying attention to the details Julie Pepe, Christina Jackson

  Commentary: Clinical Investigation

• Quality data collection: paying attention to the details Julie Pepe, Christina Jackson

  Commentary: Clinical Investigation

• Quality data collection: paying attention to the details Julie Pepe, Christina Jackson

  Commentary: Clinical Investigation

• Quality data collection: paying attention to the details Julie Pepe, Christina Jackson

  Commentary: Clinical Investigation

• Quality data collection: paying attention to the details Julie Pepe, Christina Jackson

  Commentary: Clinical Investigation

• Quality data collection: paying attention to the details Julie Pepe, Christina Jackson

  Commentary: Clinical Investigation

• Quality data collection: paying attention to the details Julie Pepe, Christina Jackson

  Commentary: Clinical Investigation

• Quality data collection: paying attention to the details Julie Pepe, Christina Jackson

  Commentary: Clinical Investigation

• Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments Timothy R Wilson & Mark R Lackner

  Clinical Trail Methodology: Clinical Investigation

• Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments Timothy R Wilson & Mark R Lackner

  Clinical Trail Methodology: Clinical Investigation

• Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments Timothy R Wilson & Mark R Lackner

  Clinical Trail Methodology: Clinical Investigation

• Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments Timothy R Wilson & Mark R Lackner

  Clinical Trail Methodology: Clinical Investigation

• Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments Timothy R Wilson & Mark R Lackner

  Clinical Trail Methodology: Clinical Investigation

• Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments Timothy R Wilson & Mark R Lackner

  Clinical Trail Methodology: Clinical Investigation

• Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments Timothy R Wilson & Mark R Lackner

  Clinical Trail Methodology: Clinical Investigation

• Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments Timothy R Wilson & Mark R Lackner

  Clinical Trail Methodology: Clinical Investigation

• Concept, characteristics and implications of cluster randomization Monica Taljaard, Jeremy M Grimshaw

  Editorial: Clinical Investigation

• Concept, characteristics and implications of cluster randomization Monica Taljaard, Jeremy M Grimshaw

  Editorial: Clinical Investigation

• Concept, characteristics and implications of cluster randomization Monica Taljaard, Jeremy M Grimshaw

  Editorial: Clinical Investigation

• Concept, characteristics and implications of cluster randomization Monica Taljaard, Jeremy M Grimshaw

  Editorial: Clinical Investigation

• Concept, characteristics and implications of cluster randomization Monica Taljaard, Jeremy M Grimshaw

  Editorial: Clinical Investigation

• Concept, characteristics and implications of cluster randomization Monica Taljaard, Jeremy M Grimshaw

  Editorial: Clinical Investigation

• Concept, characteristics and implications of cluster randomization Monica Taljaard, Jeremy M Grimshaw

  Editorial: Clinical Investigation

• Concept, characteristics and implications of cluster randomization Monica Taljaard, Jeremy M Grimshaw

  Editorial: Clinical Investigation

• Acknowledgements: Clinical Investigation Vol 3, Iss 7

  Acknowledgements: Clinical Investigation

• Acknowledgements: Clinical Investigation Vol 3, Iss 7

  Acknowledgements: Clinical Investigation

• Acknowledgements: Clinical Investigation Vol 3, Iss 7

  Acknowledgements: Clinical Investigation

• Acknowledgements: Clinical Investigation Vol 3, Iss 7

  Acknowledgements: Clinical Investigation

• Acknowledgements: Clinical Investigation Vol 3, Iss 7

  Acknowledgements: Clinical Investigation

• Acknowledgements: Clinical Investigation Vol 3, Iss 7

  Acknowledgements: Clinical Investigation

• Acknowledgements: Clinical Investigation Vol 3, Iss 7

  Acknowledgements: Clinical Investigation

• Acknowledgements: Clinical Investigation Vol 3, Iss 7

  Acknowledgements: Clinical Investigation

• What does the future hold for uveal melanoma, a historically untreatable disease? Alexander N Shoushtari , Richard D Carvajal

  Editorial: Clinical Investigation

• What does the future hold for uveal melanoma, a historically untreatable disease? Alexander N Shoushtari , Richard D Carvajal

  Editorial: Clinical Investigation

• What does the future hold for uveal melanoma, a historically untreatable disease? Alexander N Shoushtari , Richard D Carvajal

  Editorial: Clinical Investigation

• What does the future hold for uveal melanoma, a historically untreatable disease? Alexander N Shoushtari , Richard D Carvajal

  Editorial: Clinical Investigation

• What does the future hold for uveal melanoma, a historically untreatable disease? Alexander N Shoushtari , Richard D Carvajal

  Editorial: Clinical Investigation

• What does the future hold for uveal melanoma, a historically untreatable disease? Alexander N Shoushtari , Richard D Carvajal

  Editorial: Clinical Investigation

• What does the future hold for uveal melanoma, a historically untreatable disease? Alexander N Shoushtari , Richard D Carvajal

  Editorial: Clinical Investigation

• What does the future hold for uveal melanoma, a historically untreatable disease? Alexander N Shoushtari , Richard D Carvajal

  Editorial: Clinical Investigation

• Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency Jonathan Bernstein, Joseph Biedenkapp

  Review: Clinical Trail Outcomes: Clinical Investigation

• Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency Jonathan Bernstein, Joseph Biedenkapp

  Review: Clinical Trail Outcomes: Clinical Investigation

• Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency Jonathan Bernstein, Joseph Biedenkapp

  Review: Clinical Trail Outcomes: Clinical Investigation

• Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency Jonathan Bernstein, Joseph Biedenkapp

  Review: Clinical Trail Outcomes: Clinical Investigation

• Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency Jonathan Bernstein, Joseph Biedenkapp

  Review: Clinical Trail Outcomes: Clinical Investigation

• Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency Jonathan Bernstein, Joseph Biedenkapp

  Review: Clinical Trail Outcomes: Clinical Investigation

• Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency Jonathan Bernstein, Joseph Biedenkapp

  Review: Clinical Trail Outcomes: Clinical Investigation

• Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency Jonathan Bernstein, Joseph Biedenkapp

  Review: Clinical Trail Outcomes: Clinical Investigation

• Considerations on clinical trials of leprosy treatment: need of novel drug combinations Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno

  Review: Clinical Trail Outcomes: Clinical Investigation

• Considerations on clinical trials of leprosy treatment: need of novel drug combinations Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno

  Review: Clinical Trail Outcomes: Clinical Investigation

• Considerations on clinical trials of leprosy treatment: need of novel drug combinations Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno

  Review: Clinical Trail Outcomes: Clinical Investigation

• Considerations on clinical trials of leprosy treatment: need of novel drug combinations Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno

  Review: Clinical Trail Outcomes: Clinical Investigation

• Considerations on clinical trials of leprosy treatment: need of novel drug combinations Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno

  Review: Clinical Trail Outcomes: Clinical Investigation

• Considerations on clinical trials of leprosy treatment: need of novel drug combinations Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno

  Review: Clinical Trail Outcomes: Clinical Investigation

• Considerations on clinical trials of leprosy treatment: need of novel drug combinations Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno

  Review: Clinical Trail Outcomes: Clinical Investigation

• Considerations on clinical trials of leprosy treatment: need of novel drug combinations Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno

  Review: Clinical Trail Outcomes: Clinical Investigation

• Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10

  Acknowledgements: Clinical Investigation

• Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10

  Acknowledgements: Clinical Investigation

• Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10

  Acknowledgements: Clinical Investigation

• Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10

  Acknowledgements: Clinical Investigation

• Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10

  Acknowledgements: Clinical Investigation

• Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10

  Acknowledgements: Clinical Investigation

• Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10

  Acknowledgements: Clinical Investigation

• Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10

  Acknowledgements: Clinical Investigation

• HIV Vaccine Trials Network: activities and achievements of the first decade and beyond James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey

  Research Update: Clinical Investigation

• HIV Vaccine Trials Network: activities and achievements of the first decade and beyond James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey

  Research Update: Clinical Investigation

• HIV Vaccine Trials Network: activities and achievements of the first decade and beyond James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey

  Research Update: Clinical Investigation

• HIV Vaccine Trials Network: activities and achievements of the first decade and beyond James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey

  Research Update: Clinical Investigation

• HIV Vaccine Trials Network: activities and achievements of the first decade and beyond James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey

  Research Update: Clinical Investigation

• HIV Vaccine Trials Network: activities and achievements of the first decade and beyond James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey

  Research Update: Clinical Investigation

• HIV Vaccine Trials Network: activities and achievements of the first decade and beyond James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey

  Research Update: Clinical Investigation

• HIV Vaccine Trials Network: activities and achievements of the first decade and beyond James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey

  Research Update: Clinical Investigation

• Do clinical research networks work? The NIHR diabetes research network after six years Eleanor Kennedy, David R Matthews

  Research Update: Clinical Investigation

• Do clinical research networks work? The NIHR diabetes research network after six years Eleanor Kennedy, David R Matthews

  Research Update: Clinical Investigation

• Do clinical research networks work? The NIHR diabetes research network after six years Eleanor Kennedy, David R Matthews

  Research Update: Clinical Investigation

• Do clinical research networks work? The NIHR diabetes research network after six years Eleanor Kennedy, David R Matthews

  Research Update: Clinical Investigation

• Do clinical research networks work? The NIHR diabetes research network after six years Eleanor Kennedy, David R Matthews

  Research Update: Clinical Investigation

• Do clinical research networks work? The NIHR diabetes research network after six years Eleanor Kennedy, David R Matthews

  Research Update: Clinical Investigation

• Do clinical research networks work? The NIHR diabetes research network after six years Eleanor Kennedy, David R Matthews

  Research Update: Clinical Investigation

• Do clinical research networks work? The NIHR diabetes research network after six years Eleanor Kennedy, David R Matthews

  Research Update: Clinical Investigation

• Clinical investigation of desmoteplase in acute ischemic stroke: rationale and progress Monica Millan, Antoni Davalos

  Review Article: Clinical Investigation

• Clinical investigation of desmoteplase in acute ischemic stroke: rationale and progress Monica Millan, Antoni Davalos

  Review Article: Clinical Investigation

• Clinical investigation of desmoteplase in acute ischemic stroke: rationale and progress Monica Millan, Antoni Davalos

  Review Article: Clinical Investigation

• Clinical investigation of desmoteplase in acute ischemic stroke: rationale and progress Monica Millan, Antoni Davalos

  Review Article: Clinical Investigation

• Clinical investigation of desmoteplase in acute ischemic stroke: rationale and progress Monica Millan, Antoni Davalos

  Review Article: Clinical Investigation

• Clinical investigation of desmoteplase in acute ischemic stroke: rationale and progress Monica Millan, Antoni Davalos

  Review Article: Clinical Investigation

• Clinical investigation of desmoteplase in acute ischemic stroke: rationale and progress Monica Millan, Antoni Davalos

  Review Article: Clinical Investigation

• Clinical investigation of desmoteplase in acute ischemic stroke: rationale and progress Monica Millan, Antoni Davalos

  Review Article: Clinical Investigation

• New considerations in the design of clinical trials for the treatment of acute leukemia Christopher S Hourigan, Judith E Karp

  Review Article: Clinical Investigation

• New considerations in the design of clinical trials for the treatment of acute leukemia Christopher S Hourigan, Judith E Karp

  Review Article: Clinical Investigation

• New considerations in the design of clinical trials for the treatment of acute leukemia Christopher S Hourigan, Judith E Karp

  Review Article: Clinical Investigation

• New considerations in the design of clinical trials for the treatment of acute leukemia Christopher S Hourigan, Judith E Karp

  Review Article: Clinical Investigation

• New considerations in the design of clinical trials for the treatment of acute leukemia Christopher S Hourigan, Judith E Karp

  Review Article: Clinical Investigation

• New considerations in the design of clinical trials for the treatment of acute leukemia Christopher S Hourigan, Judith E Karp

  Review Article: Clinical Investigation

• New considerations in the design of clinical trials for the treatment of acute leukemia Christopher S Hourigan, Judith E Karp

  Review Article: Clinical Investigation

• New considerations in the design of clinical trials for the treatment of acute leukemia Christopher S Hourigan, Judith E Karp

  Review Article: Clinical Investigation

Relevant Topics in Clinical